Disposition of 15000 shares by Kaushal Nitin of Viemed Healthcare at 2.5 subject to Rule 16b-3
Under 67% of Tianyin Pharmaceutical's investor base is looking to short. The analysis of current outlook of investing in Tianyin Pharmaceutical Co suggests that many traders are alarmed regarding Tianyin Pharmaceutical's prospects. Tianyin Pharmaceutical's investing sentiment shows overall attitude of investors towards Tianyin Pharmaceutical Co.
Tianyin |
Filed transaction by Viemed Healthcare Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Tianyin Pharmaceutical Fundamental Analysis
We analyze Tianyin Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tianyin Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tianyin Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
Tianyin Pharmaceutical is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Tianyin Pharmaceutical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tianyin Pharmaceutical stock to make a market-neutral strategy. Peer analysis of Tianyin Pharmaceutical could also be used in its relative valuation, which is a method of valuing Tianyin Pharmaceutical by comparing valuation metrics with similar companies.
Peers
Tianyin Pharmaceutical Related Equities
| VALN | Valneva SE | 2.27 | ||||
| LPCN | Lipocine | 2.02 | ||||
| CNTA | Centessa Pharmaceuticals | 1.76 | ||||
| VMD | Viemed Healthcare | 1.29 | ||||
| AMGN | Amgen | 1.00 | ||||
| CLILF | CapitaLand Investment | 0.00 | ||||
| CTRRF | CT Real | 0.00 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Tianyin Stock
If you are still planning to invest in Tianyin Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tianyin Pharmaceutical's history and understand the potential risks before investing.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |